UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management

Haematologica (Roma), 2014-11, Vol.99 (11), p.1671-1676

2014

Volltextzugriff (PDF)

Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled study

PloS one, 2014-04, Vol.9 (4), p.e94217

2014

Volltextzugriff (PDF)

Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial

Haematologica (Roma), 2015-07, Vol.100 (7), p.955-963

2015

Volltextzugriff (PDF)

Effectiveness of Darbepoetin Alfa for Chemotherapy-induced Anemia When Initiated at Hemoglobin ≤10 g/dL

Clinical therapeutics, 2016, Vol.38 (1), p.122-135.e6

2016

Volltextzugriff (PDF)

Darbepoetin Alfa for the Treatment of Chemotherapy-Induced Anemia: Disease Progression and Survival Analysis From Four Randomized, Double-Blind, Placebo-Controlled Trials

Journal of clinical oncology, 2005-10, Vol.23 (28), p.6941-6948

2005

Volltextzugriff (PDF)

Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus > or = 10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial

BMC cancer, 2009-09, Vol.9 (1), p.311-311, Article 311

2009

Volltextzugriff (PDF)

Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double‐blind placebo‐controlled trial

British journal of haematology, 1998-05, Vol.101 (2), p.280-286

1998

Volltextzugriff (PDF)

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study

Leukemia, 2007-04, Vol.21 (4), p.627-632

2007

Volltextzugriff (PDF)

A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia

Supportive care in cancer, 2014-08, Vol.22 (8), p.2197-2206

2014

Volltextzugriff (PDF)

Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy

Medical oncology (Northwood, London, England), 2014-12, Vol.31 (12), p.302, Article 302

2014

Volltextzugriff (PDF)

Chemotherapy-induced anemia: the story of darbepoetin alfa

Current medical research and opinion, 2013-04, Vol.29 (4), p.325-337

2013

Volltextzugriff (PDF)

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double‐blind, placebo‐controlled study

British journal of haematology, 2003-08, Vol.122 (3), p.394-403

2003

Volltextzugriff (PDF)

Too-low iron doses and too many dropouts in negative iron trial?

Journal of clinical oncology, 2011-06, Vol.29 (17), p.e525-e526

2011

Volltextzugriff (PDF)

Response to Dr Coiffier

British journal of haematology, 2004-04, Vol.125 (1), p.101-102

Hedenus, Michael

2004

Volltextzugriff (PDF)

Intravenous Ferric Carboxymaltose As Sole Anemia Therapy In Patients With Lymphoid Malignancies, Chemotherapy-Induced Anemia and Functional Iron Deficiency

Blood, 2013-11, Vol.122 (21), p.3439-3439

2013

Volltextzugriff (PDF)

Impact of epoetin‐β on survival of patients with lymphoproliferative malignancies: long‐term follow up of a large randomized study

British journal of haematology, 2005-04, Vol.129 (2), p.206-209

2005

Volltextzugriff (PDF)

Effects of erythropoiesis-stimulating agents on survival and other outcomes in patients with lymphoproliferative malignancies: a study-level meta-analysis

Leukemia & lymphoma, 2012-11, Vol.53 (11), p.2151-2158

2012

Volltextzugriff (PDF)

Darbepoetin Alfa: A Viewpoint by Michael Hedenus

Drugs (New York, N.Y.), 2003-06, Vol.63 (11), p.1075-1077

Hedenus, Michael

2003

Volltextzugriff (PDF)

The role of iron supplementation during epoietin treatment for cancer-related anemia

Medical oncology (Northwood, London, England), 2009-03, Vol.26 (1), p.105-115

2009

Volltextzugriff (PDF)

Epoetin Beta with Intravenous Iron Results in Overall Cost Savings in a Population of Anemic Patients with Lymphoid Malignancies Not Receiving Chemotherapy

Blood, 2007-11, Vol.110 (11), p.5179-5179

2007

Volltextzugriff (PDF)

Pharmacovigilance in practice: erythropoiesis‐stimulating agents

Cancer medicine (Malden, MA), 2014-10, Vol.3 (5), p.1416-1429

2014

Volltextzugriff (PDF)

Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥10 g/dL: an exploratory analysis of a phase 3 trial

Medical oncology (Northwood, London, England), 2012-09, Vol.29 (3), p.2291-2299

2012

Volltextzugriff (PDF)

Randomized, dose‐finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies

British journal of haematology, 2002-10, Vol.119 (1), p.79-86

2002

Volltextzugriff (PDF)

Current Practice In Diagnosis and Treatment of Chemotherapy-Induced Anemia In Five European Countries – A Patient Record Study

Blood, 2010-11, Vol.116 (21), p.1512-1512

2010

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(45)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

British Journal Of Haematology
(8)
Blood
(6)
Medical Oncology
(4)
European Journal Of Haematology
(3)
Journal Of Clinical Oncology
(3)
Current Medical Research And Opinion
(2)
Drugs
(2)
Haematologica
(2)
Physikalische Blätter
(2)
Stroke
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management

Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled study

Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial

Effectiveness of Darbepoetin Alfa for Chemotherapy-induced Anemia When Initiated at Hemoglobin ≤10 g/dL

Darbepoetin Alfa for the Treatment of Chemotherapy-Induced Anemia: Disease Progression and Survival Analysis From Four Randomized, Double-Blind, Placebo-Controlled Trials

Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus > or = 10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial

Failure of oral pamidronate to reduce skeletal morbidity in multiple myeloma: a double‐blind placebo‐controlled trial

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study

A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia

Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy

Chemotherapy-induced anemia: the story of darbepoetin alfa

Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double‐blind, placebo‐controlled study

Too-low iron doses and too many dropouts in negative iron trial?

Response to Dr Coiffier

Intravenous Ferric Carboxymaltose As Sole Anemia Therapy In Patients With Lymphoid Malignancies, Chemotherapy-Induced Anemia and Functional Iron Deficiency

Impact of epoetin‐β on survival of patients with lymphoproliferative malignancies: long‐term follow up of a large randomized study

Effects of erythropoiesis-stimulating agents on survival and other outcomes in patients with lymphoproliferative malignancies: a study-level meta-analysis

Darbepoetin Alfa: A Viewpoint by Michael Hedenus

The role of iron supplementation during epoietin treatment for cancer-related anemia

Epoetin Beta with Intravenous Iron Results in Overall Cost Savings in a Population of Anemic Patients with Lymphoid Malignancies Not Receiving Chemotherapy

Pharmacovigilance in practice: erythropoiesis‐stimulating agents

Rituximab Maintenance Significantly Prolongs Event Free (EFS) and Progression Free Survival (PFS) In Male Patients With Aggressive B-Cell Lymphoma In The NHL13 Study

Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥10 g/dL: an exploratory analysis of a phase 3 trial

Randomized, dose‐finding study of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies

Current Practice In Diagnosis and Treatment of Chemotherapy-Induced Anemia In Five European Countries – A Patient Record Study

Suchergebnisse filtern